MedPath

长春新安药业有限公司

Ownership
-
Established
2002-06-11
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

17

NMPA:17

Drug Approvals

Prednisone Acetate Tablets

Product Name
醋酸泼尼松片
Approval Number
国药准字H22023622
Approval Date
Jul 27, 2021
NMPA

复方茶碱麻黄碱片

Approval Number
国药准字H22026031
Approval Date
Jun 4, 2020
NMPA

Compound Aspirin Tablets

Product Name
复方乙酰水杨酸片
Approval Number
国药准字H22023590
Approval Date
Jun 2, 2020
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H22023609
Approval Date
May 29, 2020
NMPA

Compound Paracetamol and Amantadine Hydrochloride Tablets

Product Name
复方氨酚烷胺片
Approval Number
国药准字H22025448
Approval Date
May 29, 2020
NMPA

痰咳清片

Approval Number
国药准字Z22024948
Approval Date
May 28, 2020
NMPA

Phenoxymethylpenicillin Potassium Tablets

Product Name
青霉素V钾片
Approval Number
国药准字H22026054
Approval Date
May 28, 2020
NMPA

Paracetamol,Caffein,Atificial Cow-bezoar

Product Name
氨咖黄敏片
Approval Number
国药准字H22024483
Approval Date
May 28, 2020
NMPA

Theophylline and Ephedrine Hydrochloride Tablets

Product Name
茶碱麻黄碱片
Approval Number
国药准字H22025453
Approval Date
May 28, 2020
NMPA

Aminopyrine and Caffeine Tablets

Product Name
氨基比林咖啡因片
Approval Number
国药准字H22026696
Approval Date
May 28, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.